Between 1 January and 31 March, Unilever’s total gross sales dipped 0.9% to €14.8bn, however grew 3% on an underlying foundation.
“We’re aware that the macroeconomic surroundings, forex stability and client sentiment stay unsure and we will probably be agile in adjusting our plans as essential,” stated CEO Fernando Fernandez when discussing the gross sales outcomes.
Fernandez, who was beforehand chief monetary officer on the British multinational, stepped into the CEO position in February, when his predecessor Hein Schumacher stepped down.
Fernandez stated there have been “interventions in place” in some rising markets to step up progress. He was optimistic concerning the high quality of the corporate’s innovation programme, including that “the robust funding behind our manufacturers and our bettering competitiveness give us confidence we’ll ship on our full-year plans.”
Model-wise, a few of Unilever’s strongest performers have been within the magnificence sector, together with Dove, Unilever’s largest model, which grew greater than 8% within the first three months, in addition to Vaseline and Liquid I.V.
Gross sales for magnificence & wellbeing manufacturers
The Magnificence & Wellbeing division grew by 4.1% on an underlying foundation.
“Development was pushed by a powerful Wellbeing efficiency, that was partially offset by a slower magnificence market,” stated the corporate.
Wellbeing delivered robust double-digit progress, led by Liquid I.V. and Nutrafol.
Hydration complement Liquid I.V. continued to realize share within the digital channels.
Olly grew with double-digit quantity, additionally pushed by a powerful efficiency in ecommerce.
Hair Care was flat with low-single digit worth offset by a low-single digit quantity decline.
Core Pores and skin Care noticed low-single digit progress, pushed by low-single digit quantity. Each Vaseline and Dove continued to develop in double-digits.
Status Magnificence declined low-single digit reflecting the slowdown within the magnificence market.
Hourglass and Tatcha continued to develop double-digit whereas Paula’s Selection and Dermalogica declined.
Premium biotech hair care model K18, grew robust double-digit and it has been included in underlying gross sales progress from February 2025.
Gross sales for private care
For Unilever’s Private Care division, underlying gross sales grew by 5.1%.
Dove, which represents round 40% of Private Care’s turnover, grew high-single digit with high-single digit quantity and optimistic worth.
“This progress was pushed by the continued success and rollout of Dove’s serum bathe assortment and whole-body deodorants,” stated Unilever.
Deodorants in the meantime, grew mid-single digit with balanced quantity and worth; Pores and skin Cleaning grew by low-single digits, pushed by optimistic quantity and worth; and Oral Care grew mid-single digit led by worth.
